Arkolith/Insider Trading/APTO/Form 4

Rice William G.

Chair, President & CEO, DirectorAptose Biosciences Inc. (APTO) · full profile →Form 4 · filed Nov 26, 2024
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2024Buy(P)100K$0.20$20K613K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 25, 2024Buy(P)50K——50K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-24-000829) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML